February 16, 2022 @ 11:00am Eastern Time
At the end of the webinar, participants will be able to:
- Define the performance of p53 immunohistochemistry as a surrogate for TP53 genetic alterations
- Differentiate 3 main patterns of p53 IHC staining (i.e., wild-type, missense, null)
- Apply p53 IHC, either singly or as part of a panel, in specific diagnostic settings in GI, GU, GYN, neuroendocrine, hematopathology, and neuropathology